Skip to main content
Premium Trial:

Request an Annual Quote

Saqqara, Cellular Genomics to Collaborate on Drug Design

NEW YORK, Oct. 6 (GenomeWeb News) - Saqqara Consultants will collaborate with Cellular Genomics on the development of structure-based drug design utilizing Saqqara's crystallization expertise, the firms announced today.

 

Terms of the agreement were not disclosed.

 

Carlsbad, Calif.-based Saqqara specializes in applying X-ray crystallography and molecular modeling to drug discovery programs. Branford, Conn.-based Cellular Genomics applied its chemical genetics platform to in-house drug discovery efforts, as well as to collaborations with pharma and biotech companies, including Affymetrix, Eli Lilly, and Pfizer. The firm recently raised $34.9 million in a Series C private financing.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more